Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$27.24 USD
+25.72 (1,692.11%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $27.24 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
VOR 27.24 +25.72(1,692.11%)
Will VOR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VOR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VOR
Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
VOR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VOR
Is VOR poised for a decline? New Downtrend shows up after crashing 10.23%
NR7 appears for VOR after 0.0% move
First Look: Nvidia's Strategic Moves and FedEx's Earnings Outlook
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale
Vor Biopharma trading halted on Thursday, news pending